Back to Trades
Gaslightwala Abizer
CEODirectorCIK 0002049375
Profile
- Filings
- 5
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Gaslightwala Abizer, CEO, Director, accounts for 5 disclosed filings worth $2.1M, all concentrated in Akari Therapeutics Plc (AKTX), active 2025–2026. The record is heavily weighted toward buying, with $19.5K in purchases against $0 in sales. The largest single open-market purchase on record is $19.5K in Akari Therapeutics Plc. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Oct 16 | AKTX Akari Therapeutics Plc | Gaslightwala Abizer | CEO, Director | Exercise | $1.4M |
| Oct 1 | AKTX Akari Therapeutics Plc | Gaslightwala Abizer | CEO, Director | Grant | $62.5K |
| Jun 25 | AKTX Akari Therapeutics Plc | Gaslightwala Abizer | CEO, Director | Award | $253.2K |
| Dec 18 | AKTX Akari Therapeutics Plc | Gaslightwala Abizer | CEO, Director | Other | $420.4K |
| Aug 29 | AKTX Akari Therapeutics Plc | Gaslightwala Abizer | CEO, Director | Buy | $19.5K |
5 filings